TY - JOUR T1 - Funding for treatment of adult Obstructive Sleep Apnoea in England JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.sleepandbreathing-2021.33 VL - 7 IS - suppl 7 SP - 33 AU - K Chaidas AU - A Ashman Y1 - 2021/04/16 UR - http://openres.ersjournals.com/content/7/suppl_7/33.abstract N2 - Introduction - Objective: Various therapeutic options for obstructive sleep apnoea (OSA) exist in published guidelines worldwide. The aim of this study was to review the funding policies of Clinical Commissioning Groups (CCGs) for the treatment of OSA in England.Methods: We reviewed published policies from a randomly selected sample of 60 out of 190 CCGs.Results: Continuous positive airway pressure (CPAP) was funded based on a clinical assessment or according to criteria that were in line with national guidelines in most CCGs (49/60), with 11 CCGs offering no policy. Mandibular advancement devices, tonsillectomy, and nasal surgery were funded based on a clinical assessment or certain criteria in 16, 25, and 16 CCGs, respectively. In contrast, only one CCG provided funding for soft palate, tongue base and/or mandibular surgery. Hypoglossal nerve stimulation was not mentioned in any CCG’s policy.Conclusion: Whilst most CCGs provide funding for the use of CPAP, the availability of funding for other OSA treatment modalities is heterogeneous leaving CPAP intolerant patients in some regions with limited therapeutic options.FootnotesCite this article as ERJ Open Research 2021; 7: Suppl. 7, 33.This is an ERS Lung Science Conference abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -